M
Magnus Unemo
Researcher at Örebro University
Publications - 465
Citations - 22073
Magnus Unemo is an academic researcher from Örebro University. The author has contributed to research in topics: Neisseria gonorrhoeae & Antibiotic resistance. The author has an hindex of 62, co-authored 418 publications receiving 17623 citations. Previous affiliations of Magnus Unemo include World Health Organization.
Papers
More filters
Journal ArticleDOI
Global Estimates of the Prevalence and Incidence of Four Curable Sexually Transmitted Infections in 2012 Based on Systematic Review and Global Reporting
Lori M. Newman,Jane Rowley,Stephen Vander Hoorn,Stephen Vander Hoorn,Nalinka Saman Wijesooriya,Magnus Unemo,Nicola Low,Gretchen A Stevens,Sami L Gottlieb,James Kiarie,Marleen Temmerman +10 more
TL;DR: Estimates of the global prevalence and incidence of chlamydia, gonorrhoea, trichomoniasis, and syphilis in adult women and men remain high, with nearly one million new infections with curable STI each day.
Journal ArticleDOI
Chlamydia, gonorrhoea, trichomoniasis and syphilis: global prevalence and incidence estimates, 2016.
Jane Rowley,Stephen Vander Hoorn,Eline L. Korenromp,Nicola Low,Magnus Unemo,Laith J. Abu-Raddad,R Matthew Chico,Alex Smolak,Lori M. Newman,Sami L Gottlieb,Soe Soe Thwin,Nathalie Broutet,Melanie M Taylor +12 more
TL;DR: The study highlights the need to expand data collection efforts at country level and provides an initial baseline for monitoring progress of the World Health Organization global health sector strategy on sexually transmitted infections 2016–2021.
Journal ArticleDOI
Antimicrobial Resistance in Neisseria gonorrhoeae in the 21st Century: Past, Evolution, and Future
TL;DR: By understanding the evolution, emergence, and spread of AMR in N. gonorrhoeae, including its molecular and phenotypic mechanisms, resistance to antimicrobials used clinically can be anticipated, and future methods for genetic testing for AMR might permit region-specific and tailor-made antimicrobial therapy, the design of novel antimicroBials to circumvent the resistance problems can be undertaken more rationally.
Journal ArticleDOI
Is Neisseria gonorrhoeae Initiating a Future Era of Untreatable Gonorrhea?: Detailed Characterization of the First Strain with High-Level Resistance to Ceftriaxone
Makoto Ohnishi,Daniel Golparian,Ken Shimuta,Takeshi Saika,Shinji Hoshina,Kazuhiro Iwasaku,Shu Ichi Nakayama,Jo Kitawaki,Magnus Unemo +8 more
TL;DR: A detailed characterization of the first Neisseria gonorrhoeae strain, H041, was performed to confirm the finding, examine its antimicrobial resistance (AMR), and elucidate the resistance mechanisms.
Journal ArticleDOI
High-level cefixime- and ceftriaxone-resistant Neisseria gonorrhoeae in France: novel penA mosaic allele in a successful international clone causes treatment failure.
Magnus Unemo,Daniel Golparian,Robert A. Nicholas,Makoto Ohnishi,Anne Gallay,Patrice Sednaoui +5 more
TL;DR: F89 has high-level resistance to cefixime and ceftriaxone and resistance to most other antimicrobials examined and is assigned to MLST sequence type 1901 and NG-MAST ST1407, which is a successful gonococcal clone that has spread globally.